BRT APARTMENTS CORP (BRT)

US0556453035 - REIT

16.8  +0.35 (+2.13%)

After market: 16.5 -0.3 (-1.79%)

Fundamental Rating

3

Overall BRT gets a fundamental rating of 3 out of 10. We evaluated BRT against 21 industry peers in the Residential REITs industry. BRT has a bad profitability rating. Also its financial health evaluation is rather negative. BRT is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year BRT was profitable.
In the past year BRT had a positive cash flow from operations.
BRT had positive earnings in 4 of the past 5 years.
In multiple years BRT reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of 0.55%, BRT perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
BRT has a Return On Equity (1.70%) which is in line with its industry peers.
With a Return On Invested Capital value of 0.90%, BRT is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.55%
ROE 1.7%
ROIC 0.9%
ROA(3y)4.57%
ROA(5y)1.7%
ROE(3y)12.01%
ROE(5y)5.06%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of BRT (4.14%) is comparable to the rest of the industry.
BRT's Profit Margin has declined in the last couple of years.
BRT has a worse Operating Margin (8.41%) than 80.95% of its industry peers.
BRT's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 55.33%, BRT is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BRT has remained more or less at the same level.
Industry RankSector Rank
OM 8.41%
PM (TTM) 4.14%
GM 55.33%
OM growth 3YN/A
OM growth 5Y-6.78%
PM growth 3YN/A
PM growth 5Y-26.96%
GM growth 3Y-0.33%
GM growth 5Y1.31%

3

2. Health

2.1 Basic Checks

BRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BRT has been reduced compared to 1 year ago.
BRT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BRT has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.48, we must say that BRT is in the distress zone and has some risk of bankruptcy.
BRT has a worse Altman-Z score (0.48) than 71.43% of its industry peers.
BRT has a debt to FCF ratio of 46.13. This is a negative value and a sign of low solvency as BRT would need 46.13 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 46.13, BRT is doing good in the industry, outperforming 61.90% of the companies in the same industry.
BRT has a Debt/Equity ratio of 2.01. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.01, BRT is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.01
Debt/FCF 46.13
Altman-Z 0.48
ROIC/WACC0.14
WACC6.54%

2.3 Liquidity

A Current Ratio of 1.07 indicates that BRT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.07, BRT is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
BRT has a Quick Ratio of 1.07. This is a normal value and indicates that BRT is financially healthy and should not expect problems in meeting its short term obligations.
BRT has a Quick ratio of 1.07. This is in the better half of the industry: BRT outperforms 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07

3

3. Growth

3.1 Past

BRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.92%.
Measured over the past years, BRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.10% on average per year.
The Revenue has grown by 32.74% in the past year. This is a very strong growth!
The Revenue has been decreasing by -4.78% on average over the past years.
EPS 1Y (TTM)-93.92%
EPS 3YN/A
EPS 5Y-33.1%
EPS growth Q2Q50%
Revenue 1Y (TTM)32.74%
Revenue growth 3Y49.35%
Revenue growth 5Y-4.78%
Revenue growth Q2Q3.51%

3.2 Future

Based on estimates for the next years, BRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -137.82% on average per year.
The Revenue is expected to grow by 2.62% on average over the next years.
EPS Next Y-484.17%
EPS Next 2Y-137.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.41%
Revenue Next 2Y4.06%
Revenue Next 3Y2.32%
Revenue Next 5Y2.62%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 105.00 indicates a quite expensive valuation of BRT.
The rest of the industry has a similar Price/Earnings ratio as BRT.
Compared to an average S&P500 Price/Earnings ratio of 26.48, BRT is valued quite expensively.
The Forward Price/Earnings Ratio is negative for BRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 105
Fwd PE N/A

4.2 Price Multiples

BRT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BRT is more expensive than 66.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BRT is valued cheaper than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.33
EV/EBITDA 20.4

4.3 Compensation for Growth

BRT's earnings are expected to decrease with -137.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-137.82%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.97%, BRT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.46, BRT pays a better dividend. On top of this BRT pays more dividend than 95.24% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, BRT pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.97%

5.2 History

The dividend of BRT has a limited annual growth rate of 5.54%.
BRT has paid a dividend for at least 10 years, which is a reliable track record.
BRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)5.54%
Div Incr Years6
Div Non Decr Years6

5.3 Sustainability

BRT pays out 488.23% of its income as dividend. This is not a sustainable payout ratio.
BRT's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP488.23%
EPS Next 2Y-137.82%
EPS Next 3YN/A

BRT APARTMENTS CORP

NYSE:BRT (3/28/2024, 7:01:49 PM)

After market: 16.5 -0.3 (-1.79%)

16.8

+0.35 (+2.13%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap312.14M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.97%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 105
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.55%
ROE 1.7%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.41%
PM (TTM) 4.14%
GM 55.33%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 2.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-93.92%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-484.17%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)32.74%
Revenue growth 3Y49.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y